Company · CIK 0001075880 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
KAZIA THERAPEUTICS LTD · KZIA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2026 AForm 4 → | Jun 23, 6:47 pm EDT | James E. LevineChief Financial Officer | 200,000 | — | — | 200,000 | — | |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:47 pm EDT | Sudha RaoChief Scientific Officer | 250,000 | — | — | 250,000 | — |